Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05191706 · ClinicalTrials.gov registry record · Phase 4
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
A Phase 4 study of Cataract, sponsored by EyePoint Pharmaceuticals.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 9
- Study locations
NCT05191706 is a Phase 4 study of Cataract that is actively recruiting participants, run by EyePoint Pharmaceuticals. The registered enrollment target is 60 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (74% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT05191706, a Phase 4 study of Cataract, is actively recruiting participants, sponsored by EyePoint Pharmaceuticals.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 9
- Study locations
Study Summary
A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Prednisolone Acetate Ophthalmic
Study Locations (9)
New York
- EyePoint Investigational Site - Buffalo
- EyePoint Investigative Site - New York
- EyePoint Investigational Site - Rochester
California
- EyePoint Investigational Site - Huntington Beach
- EyePoint Investigational Site - Palo Alto
Massachusetts
- EyePoint Investigative Site - Boston
Mississippi
- EyePoint Investigational Site - Jackson
Nebraska
- EyePoint Investigational Site - Omaha
South Carolina
- EyePoint Investigational Site - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2026-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05191706
The ClinicalTrials.gov registry entry for NCT05191706 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (74% lower). The listed sponsor is EyePoint Pharmaceuticals, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT05191706 reports 9 study locations spanning 6 distinct geographic areas - top geographies include New York, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05191706 about?
NCT05191706 is a clinical study titled "Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract". A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
What is the current status of trial NCT05191706?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2022-01-04. Estimated completion is 2026-02.
What conditions does trial NCT05191706 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT05191706?
The interventions under investigation include: Dexamethasone (DRUG), Prednisolone Acetate Ophthalmic (DRUG).
Who is sponsoring clinical trial NCT05191706?
This trial is sponsored by EyePoint Pharmaceuticals, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05191706 being conducted?
This trial has 9 study locations across California, Massachusetts, Mississippi, Nebraska, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
-
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.